All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

331

Reset

331 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • QLS7305Phase 21 trial

    Qilu Pharmaceutical Co., Ltd. · IgAN - IgA Nephropathy, Immune Complex Membranoproliferative Glomerulonephritis (IC-MPGN), C3 Glomerulopathy (C3G)

  • REGN15505Phase 21 trial

    Regeneron · Metastatic Castration-Resistant Prostate Cancer (mCRPC), Clear Cell Renal Cell Carcinoma (ccRCC)

  • REGN21353Phase 21 trial

    Regeneron · Metastatic Castration-Resistant Prostate Cancer, mCRPC

  • RG002C0106Phase 21 trial

    Rigerna Therapeutics Co., Ltd.; Rigerna Therapeutics (Beijing) Co., Ltd. · IgA Nephropathy (IgAN)

  • RMC-035Phase 21 trial

    Guard Therapeutics AB · Kidney Injury Following Open-Chest Cardiac Surgery

  • RS-113Phase 21 trial

    R-Pharm International, LLC · Metastatic Castration-resistant Prostate Cancer

  • RV001VPhase 21 trial

    RhoVac APS · Prostate Cancer Recurrent

  • RYZ711Phase 21 trial

    RayzeBio, Inc. · Prostate Cancer (Adenocarcinoma), Adenocarcinoma of the Prostate, Metastatic Castration-resistant Prostate Cancer (mCRPC)

  • TransThera Sciences (Nanjing), Inc. · Prostate Cancer (CRPC)

  • SFG-02Phase 21 trial

    Juro Sciences Inc. · Participants With Underactive Bladder (UAB)

  • SHR-4394Phase 21 trial

    Jiangsu HengRui Medicine Co., Ltd. · Prostate Cancer

  • SHR3680Phase 21 trial

    Jiangsu HengRui Medicine Co., Ltd. · Prostate Cancer

  • SNS-101anti-VISTAPhase 21 trial

    Sensei Biotherapeutics, Inc. · Solid Tumor, Adult, Advanced Solid Tumor, Head and Neck Cancer

  • SPH3127Phase 21 trial

    Shanghai Pharmaceuticals Holding Co., Ltd · Diabetic Kidney Disease

  • ST-067Phase 21 trial

    Simcha IL-18, Inc. · Cancer, Solid Tumor, Melanoma

  • ST101Phase 21 trial

    Sapience Therapeutics · Glioblastoma, Melanoma Stage IV, Breast Cancer

  • STM-416Phase 21 trial

    SURGE Therapeutics · Non-muscle-invasive Bladder Cancer

  • SV-102Phase 21 trial

    Syncromune, Inc. · Metastatic Castration-resistant Prostate Cancer

  • SX-682Phase 21 trial

    Syntrix Biosystems, Inc. · Metastatic Castration-resistant Prostate Cancer

  • Astellas · Intestine Transplantation, Kidney Transplantation, Lung Transplantation

  • TB511Phase 21 trial

    Twinpig Biolab, Inc. · NSCLC, Prostate Cancer, Colorectal Cancer

  • TD001Phase 21 trial

    T.O.A.D. Oncology SA · Metastatic Castration-Resistant Prostatic Cancer

  • TQB3201Phase 21 trial

    Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Metastatic Castration-resistant Prostate Cancer

  • TRG-200Phase 21 trial

    Trigone Pharma Ltd. · Overactive Bladder (OAB)

  • TT-10Phase 21 trial

    Portage Biotech · Renal Cell Cancer, Castrate Resistant Prostate Cancer, Non Small Cell Lung Cancer

  • TY-302Phase 21 trial

    TYK Medicines, Inc · Metastatic Castration-resistant Prostate Cancer (mCRPC)

  • VB15010Phase 21 trial

    Zhejiang Yangli Pharmaceutical Technology Co., Ltd. · Cancer, Neoplasms, Neoplasms, Breast

  • VEL-101Pegrizeprument, FR104Phase 21 trial

    Asahi Kasei Therapeutics, Inc. · Transplantation, Kidney

  • VMD-102Single agentPhase 21 trial

    VM Discovery, Inc. · Hepatocellular Carcinoma (HCC), Metastatic Uveal Melanoma, Renal Cell Carcinoma (RCC)

  • VX-407Phase 21 trial

    Vertex Pharmaceuticals · Autosomal Dominant Polycystic Kidney Disease (ADPKD)

  • WAL0921Phase 21 trial

    Walden Biosciences · Diabetic Nephropathies, Primary Focal Segmental Glomerulosclerosis, Minimal Change Disease

NewerPage 7 of 7

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.